SEC Form 4 · accession 0001127602-16-053313
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Causey
Director
Period of report
May 20, 2016
Accepted (ET)
May 25, 2016 · 8:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2016 | M | 750 | $51.77 | A | 1,855 | D | |
| Common Stock | May 20, 2016 | D | 750 | $113.62 | D | 1,105 | D | |
| Common Stock | holding | — | — | — | 0 | I | By Ugma Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $51.77 | May 20, 2016 | M | 750 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 750 | 11,250 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.